Browse > Article
http://dx.doi.org/10.5667/CellMed.2020.0023

Clinical Effectiveness of a Unani Regimen in the Management of Hasāh al-kuliya (Nephrolithiasis): A Case Report  

Qaiyyum, Ifra Abdul (Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders)
Nawab, Mohammad (Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders)
Publication Information
CELLMED / v.10, no.3, 2020 , pp. 23.1-23.5 More about this Journal
Abstract
Hasāh al-kuliya (Nephrolithiasis) is a common disease with a worldwide prevalence of about 12%. A 64 years old male patient, who visited the outpatient department of National Research Institute of Unani Medicine for Skin Disorder (NRIUMSD), Hyderabad, presented with complaints of mild dull pain in right flank region and burning micturition for one month. The ultrasonography of whole abdomen confirmed that there was one stone of 5 mm in calyceal region of each kidney. The patient was treated with the Unani regimen comprising of three formulations Majoon, Hajrul Yahood (5 gm), Jawarish Zarooni Sada (5 gm) and Habb-i-Mudir (1000 mg) for 6 months. The patient did not report any acute pain during the therapy. After 6 months of treatment the ultrasonography of whole abdomen showed absence of the stone from each kidney, ureters and bladder. There was no recurrence of the disease during next 6 months of post treatment follow up. This case report documented the successful medical treatment and prevention of recurrence of bilateral nephrolithiasis through Unani medicines. It concluded that the Unani regimen was effective and safe in the management of bilateral nephrolithiasis.
Keywords
$Has{\bar{a}}h$ al-kuliya; Majoon Hazrul Yahood; Nephrolithiasis; Renal Stone; Unani medicine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Afzal M, Khan NA, Ghufran A, Iqbal A, & Inamuddin M. Diuretic and nephroprotective effect of Jawarish Zarooni Sada - A polyherbal unani formulation. Journal of Ethnopharmacology, 2004;91(2-3);219-223.   DOI
2 Alelign T & Petros B. Kidney Stone Disease: An Update on Current Concepts. Advances in Urology, 2018.
3 Al-Majusi. Ibn 'Abbas. Tarjuma-i Kamilus Sana' (Urdu Trans. by Ghulam Hussain Kantoori), Vol. 1&2. 1889
4 Arzani AM. Qarabadeen-e-qadri, (New Delhi, India; Council for Research in Unani Medicine), pp.517, 2009
5 Butterweck V & Khan SR. Herbal medicines in the management of urolithiasis: Alternative or complementary? Planta Medica, 2009;75(10);1095-1103.   DOI
6 Joseph KC, Parekh BB & Joshi MJ. Inhibition of growth of urinary type calcium hydrogen phosphate dihydrate crystals by tartaric acid and tamarind. Current Science, 2005;88(8);1232-1238.
7 Knoll T. Epidemiology, pathogenesis, and pathophysiology of urolithiasis. European Urology, Supplements, 2010;9(12);802-806.   DOI
8 Makbul SAA, Jahan N & Ahmad G. Hajrul yahood (Lapis judaicus): An important mineral drug of Unani system of medicine for the management of urolithiasis. Journal of Ethnopharmacology, 2018;222;165-170.   DOI
9 Mohammed Tabarak Hussain I, Ahmed G, Jahan N & Adiba M. Pathophysiology and Treatment of Urolithiasis in Unani Medicine. Indian Journal of History of Science, 2016; 51(2).
10 Portis AJ & Sundaram CP. Diagnosis and initial management of kidney stones. American Family Physician, 2001;63(7);1329-1338.
11 Soni S, Saboo S, Bhansali A & Barnela S. Medical management of renal stone. Indian Journal of Endocrinology and Metabolism, 2012;16(2);236.   DOI
12 Worcester EM & Coe FL. Nephrolithiasis. Primary Care - Clinics in Office Practice, 2008;35(2);369-391.   DOI
13 Anonymous, National Formulary of Unani Medicine, part-1, (New Delhi, India; Central Council for Research in Unani Medicine), pp.24, 106, 127, 2006.